Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMETS: Sequence of FOLFOX-4 and Cetuximab/Irinotecan in mCRC
NCT01030042Phase 3Completed
- Sponsor
- Fondazione Giscad per la Ricerca sui Tumori
- Start
- Sep 2009
- Primary completion
- Apr 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of KL-140 in metastatic colorectal cancer (mCRC), sponsored by Fondazione Giscad per la Ricerca sui Tumori. Started Sep 2009; status: completed.
02
Drugs
KL-140
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01030042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01030042.